CD28 and rheumatoid arthritis: Towards this end, we measured cytokines associated with RA progression in CD4+ T cells from healthy donors under UBASH3A-overexpressing conditions, with and without treatment with CD3 and CD28 antibodies (Fig. 5A–D).